Clinical trial
Nitroprusside for Prevention of no-Reflow in Primary Angioplasty
NCT00128791 · Soroka University Medical Center, Other · Terminated
Key facts
| NCT number | NCT00128791 |
|---|---|
| Title | Nitroprusside for Prevention of no-Reflow in Primary Angioplasty |
| Official title | Intracoronary Nitroprusside for the Prevention of the No-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. A Randomized, Double Blind, Placebo-Controlled Clinical Trial |
| Lead sponsor | Soroka University Medical Center, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Nitroprusside |
| Enrollment | 100 |
| Start date | Jan 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Aug 10, 2005 |
| Last update posted | May 25, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: